|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019.
|
|
2
|
Noone AM, Cronin KA, Altekruse SF,
Howlader N, Lewis DR, Petkov VI and Penberthy L: Cancer incidence
and survival trends by subtype using data from the Surveillance
Epidemiology and End Results (SEER) Program, 1992-2013. Cancer
Epidemiol Biomarkers Prev. 26:632–641. 2017. View Article : Google Scholar
|
|
3
|
Wang L, Yang GH, Li H and Lu XH: The
changing pancreatic cancer mortality in China (1991-2000). Zhonghua
Nei Ke Za Zhi. 44:509–513. 2005.In Chinese. PubMed/NCBI
|
|
4
|
Cancer.Net: Pancreatic Cancer: Statistics.
American Society of Clinical Oncology ASCO; 2018
|
|
5
|
Malvezzi M, Carioli G, Bertuccio P, Rosso
T, Boffetta P, Levi F, La Vecchia C and Negri E: European cancer
mortality predictions for the year 2016 with focus on leukaemias.
Ann Oncol. 27:725–731. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel RL, Jemal A, Wender RC, Gansler T,
Ma J and Brawley OW: An assessment of progress in cancer control.
CA Cancer J Clin. 68:329–339. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hidalgo M, Cascinu S, Kleeff J, Labianca
R, Löhr JM, Neoptolemos J, Real FX, Van Laethem JL and Heinemann V:
Addressing the challenges of pancreatic cancer: Future directions
for improving outcomes. Pancreatology. 15:8–18. 2015. View Article : Google Scholar
|
|
8
|
Jones S, Zhang X, Parsons DW, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et
al: Core signaling pathways in human pancreatic cancers revealed by
global genomic analyses. Science. 321:1801–1806. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du YX, Liu ZW, You L, Wu WM and Zhao YP:
Advances in understanding the molecular mechanism of pancreatic
cancer metastasis. Hepatobiliary Pancreat Dis Int. 15:361–370.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rhim AD, Oberstein PE, Thomas DH, Mirek
ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP,
Tattersall IW, et al: Stromal elements act to restrain, rather than
support, pancreatic ductal adenocarcinoma. Cancer Cell. 25:735–747.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao K, Liang G, Sun X and Guan L:
Comparative miRNAome analysis revealed different miRNA expression
profiles in bovine sera and exosomes. BMC Genomics. 17:6302016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carmicheal J, Hayashi C, Huang X, Liu L,
Lu Y, Krasnoslobodtsev A, Lushnikov A, Kshirsagar PG, Patel A, Jain
M, et al: Label-free characterization of exosome via surface
enhanced Raman spectroscopy for the early detection of pancreatic
cancer. Nanomedicine (Lond). 16:88–96. 2019. View Article : Google Scholar
|
|
14
|
Jiang XT, Tao HQ and Zou SC: Detection of
serum tumor markers in the diagnosis and treatment of patients with
pancreatic cancer. Hepatobiliary Pancreat Dis Int. 3:464–468.
2004.PubMed/NCBI
|
|
15
|
Tanaka T, Ikari K, Furushima K, Okada A,
Tanaka H, Furukawa K, Yoshida K, Ikeda T, Ikegawa S, Hunt SC, et
al: Genomewide linkage and linkage disequilibrium analyses identify
COL6A1, on chromosome 21, as the locus for ossification of the
posterior longitudinal ligament of the spine. Am J Hum Genet.
73:812–822. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
357:3572017. View Article : Google Scholar
|
|
17
|
Pontén F, Jirström K and Uhlen M: The
Human Protein Atlas–a tool for pathology. J Pathol. 216:387–393.
2008. View Article : Google Scholar
|
|
18
|
Hou T, Tong C, Kazobinka G, Zhang W, Huang
X, Huang Y and Zhang Y: Expression of COL6A1 predicts prognosis in
cervical cancer patients. Am J Transl Res. 8:2838–2844.
2016.PubMed/NCBI
|
|
19
|
Zhu YP, Wan FN, Shen YJ, Wang HK, Zhang GM
and Ye DW: Reactive stroma component COL6A1 is upregulated in
castration-resistant prostate cancer and promotes tumor growth.
Oncotarget. 6:14488–14496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiu KH, Chang YH, Wu YS, Lee SH and Liao
PC: Quantitative secretome analysis reveals that COL6A1 is a
metastasis-associated protein using stacking gel-aided purification
combined with iTRAQ labeling. J Proteome Res. 10:1110–1125. 2011.
View Article : Google Scholar
|
|
21
|
Birnbaum DJ, Adélaïde J, Mamessier E,
Finetti P, Lagarde A, Monges G, Viret F, Gonçalvès A, Turrini O,
Delpero JR, et al: Genome profiling of pancreatic adenocarcinoma.
Genes Chromosomes Cancer. 50:456–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iacobuzio-Donahue CA: Genetic evolution of
pancreatic cancer: Lessons learnt from the pancreatic cancer genome
sequencing project. Gut. 61:1085–1094. 2012. View Article : Google Scholar :
|
|
23
|
Moriggi M, Giussani M, Torretta E,
Capitanio D, Sandri M, Leone R, De Palma S, Vasso M, Vozzi G,
Tagliabue E, et al: ECM remodeling in breast cancer with different
grade: Contribution of 2D-DIGE proteomics. Proteomics.
18:e18002782018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chun YS, Pawlik TM and Vauthey JN: 8th
Edition of the AJCC Cancer Staging Manual: Pancreas and
Hepatobiliary Cancers. Ann Surg Oncol. 25:845–847. 2018. View Article : Google Scholar
|
|
25
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: a web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Escobar-Hoyos LF, Shah R, Roa-Peña L,
Vanner EA, Najafian N, Banach A, Nielsen E, Al-Khalil R, Akalin A,
Talmage D, et al: Keratin-17 promotes p27KIP1 nuclear
export and degradation and offers potential prognostic utility.
Cancer Res. 75:3650–3662. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alkushi A: Validation of tissue microarray
biomarker expression of breast carcinomas in Saudi women. Hematol
Oncol Stem Cell Ther. 2:394–398. 2009. View Article : Google Scholar
|
|
29
|
Miura K, Kimura K, Amano R, Yamazoe S,
Ohira G, Murata A, Nishio K, Hasegawa T, Yashiro M, Nakata B, et
al: Establishment and characterization of new cell lines of
anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1
and OCUP-A2. BMC Cancer. 16:2682016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Torres MP, Rachagani S, Souchek JJ, Mallya
K, Johansson SL and Batra SK: Novel pancreatic cancer cell lines
derived from genetically engineered mouse models of spontaneous
pancreatic adenocarcinoma: Applications in diagnosis and therapy.
PLoS One. 8:e805802013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sato T, Takano R, Takahara N, Tokunaka K,
Saiga K, Tomura A, Sugihara H, Hayashi T, Imamura Y and Morita M:
Identification of a common epitope in the sequences of COL4A1 and
COL6A1 recognized by monoclonal antibody #141. J Biochem.
165:85–95. 2019. View Article : Google Scholar
|
|
32
|
Qiu W and Su GH: Challenges and advances
in mouse modeling for human pancreatic tumorigenesis and
metastasis. Cancer Metastasis Rev. 32:83–107. 2013. View Article : Google Scholar
|
|
33
|
Pan Y, Gao S, Hua YQ and Liu LM:
Establishment of a pancreatic cancer stem cell model using the
SW1990 human pancreatic cancer cell line in nude mice. Asian Pac J
Cancer Prev. 16:437–442. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim MJ, Kim MS, Kim SJ, An S, Park J, Park
H, Lee JH, Song KB, Hwang DW, Chang S, et al: Establishment and
characterization of 6 novel patient-derived primary pancreatic
ductal adenocarcinoma cell lines from Korean pancreatic cancer
patients. Cancer Cell Int. 17:472017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Krzykawski MP, Krzykawska-Serda M,
Jasińska K and Marcinkiewicz J: Pan_02 murine pancreatic cancer
model. Folia Med Cracov. 55:15–24. 2015.
|
|
36
|
Jian Z, Cheng T, Zhang Z, Raulefs S, Shi
K, Steiger K, Maeritz N, Kleigrewe K, Hofmann T, Benitz S, et al:
Glycemic variability promotes both local invasion and metastatic
colonization by pancreatic ductal adenocarcinoma. Cell Mol
Gastroenterol Hepatol. 6:429–449. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fujita A, Sato JR, Festa F, Gomes LR,
Oba-Shinjo SM, Marie SK, Ferreira CE and Sogayar MC: Identification
of COL6A1 as a differentially expressed gene in human astrocytomas.
Genet Mol Res. 7:371–378. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Whittle MC, Izeradjene K, Rani PG, Feng L,
Carlson MA, DelGiorno KE, Wood LD, Goggins M, Hruban RH, Chang AE,
et al: RUNX3 controls a metastatic switch in pancreatic ductal
adenocarcinoma. Cell. 161:1345–1360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sato T, Takano R, Tokunaka K, Saiga K,
Tomura A, Sugihara H, Hayashi T, Imamura Y and Morita M: Type VI
collagen α1 chain polypeptide in non-triple helical form is an
alternative gene product of COL6A1. J Biochem. 164:173–181. 2018.
View Article : Google Scholar : PubMed/NCBI
|
